Back to Results
First PageMeta Content
Acute myeloid leukemia / Myeloid leukemia / Clinical research / Design of experiments / Myelodysplastic syndrome / Astex / Clinical trial / Medicine / Health / Acute leukemia


June 22, 2012 Astex Pharmaceuticals Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients DUBLIN, Calif., June 22, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasd
Add to Reading List

Open Document

File Size: 58,57 KB

Share Result on Facebook

City

DUBLIN / Chicago / /

Company

Astex Pharmaceuticals Inc. / Astex Pharmaceuticals Astex Pharmaceuticals / Astex Pharmaceuticals / /

Event

FDA Phase / /

IndustryTerm

pharmaceutical / /

MedicalCondition

Up To Cancer / acute myeloid leukemia / /

MedicalTreatment

platelet transfusions / /

Organization

American Association for Cancer Research / /

Person

James S.J. Manuso / Mohammad Azab / /

Position

chief medical officer / chairman & chief executive officer / /

Product

Dacogen / SGI-110 / PK/PD / /

ProvinceOrState

Illinois / California / /

PublishedMedium

Cancer Research / /

URL

www.astx.com / http /

SocialTag